Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China

2 abstracts

Abstract
Neoadjuvant tislelizumab plus chemotherapy followed by salvage surgery and adjuvant tislelizumab for recurrent head and neck squamous cell carcinoma after radiotherapy: A single-arm, phase II trial.
Org: Peking University School and Hospital of Stomatology, Beijing, China, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China,
Abstract
Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: A single-arm, phase II trial.
Org: Peking University School and Hospital of Stomatology, Beijing, China, Fu Xing Hospital, Capital Medical University, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China,